A novel recognition motif for phosphatidylinositol 3-kinase binding mediates its association with the hepatocyte growth factor/scatter factor receptor

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Molecular and Cellular Biology

• Publication date

  1993-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1128/mcb.13.8.4600-4608.1993PMID 7687741PMCID PMC360084
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• SH 2 Domains Recognize Specific Phosphopeptide Sequences

  2004cited by this paper
• Electroporation of peptides into adherent cells in situ.

  1995cited by this paper
• Regulation of scatter factor/hepatocyte growth factor responses by Ras, Rac, and Rho in MDCK cells

  1995cited by this paper
• Protein modules and signalling networks

  1995cited by this paper
• Transcriptional responses to polypeptide ligands: the JAK-STAT pathway.

  1995cited by this paper
• The motogenic and mitogenic responses to HGF are amplified by the Shc adaptor protein.

  1995cited by this paper
• Hepatocyte Growth Factor-induced Scatter of Madin-Darby Canine Kidney Cells Requires Phosphatidylinositol 3-Kinase (*)

  1995cited by this paper
• Searching Sequence Space

  1995cited by this paper
• DNA shuffling by random fragmentation and reassembly: in vitro recombination for molecular evolution.

  1994cited by this paper
• Hepatocyte growth factor (HGF) receptor expression is inducible and is part of the delayed-early response to HGF.

  1994cited by this paper
• Rapid evolution of a protein in vitro by DNA shuffling

  1994cited by this paper
• Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells.

  1993cited by this paper
• Hepatocyte growth factor/scatter factor stimulates the Ras-guanine nucleotide exchanger.

  1993cited by this paper
• Interferon-induced nuclear signalling by Jak protein tyrosine kinases

  1993cited by this paper
• Interactions between SH2 domains and tyrosine-phosphorylated platelet-derived growth factor beta-receptor sequences: analysis of kinetic parameters by a novel biosensor-based approach

  1993cited by this paper
• Phosphoinositide 3-kinase is activated by phosphopeptides that bind to the SH2 domains of the 85-kDa subunit.

  1993cited by this paper
• Evolution of an enzyme activity: crystallographic structure at 2-A resolution of cephalosporinase from the ampC gene of Enterobacter cloacae P99 and comparison with a class A penicillinase.

  1993cited by this paper
• Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways.

  1992influential reference
• Phosphatidyl-inositol 3-kinase: a key enzyme in diverse signalling processes.

  1992cited by this paper
• Phosphorylation sites in the PDGF receptor with different specificities for binding GAP and PI3 kinase in vivo.

  1992influential reference
• Identification of phosphotyrosine residues in peptides by high performance liquid chromatography on-line derivative spectroscopy.

  1992cited by this paper
• Autophosphorylation promotes complex formation of recombinant hepatocyte growth factor receptor with cytoplasmic effectors containing SH2 domains.

  1992cited by this paper
• Modification of the 85-kilodalton subunit of phosphatidylinositol-3 kinase in platelet-derived growth factor-stimulated cells

  1992cited by this paper
• The C-terminal SH2 domain of p85 accounts for the high affinity and specificity of the binding of phosphatidylinositol 3-kinase to phosphorylated platelet-derived growth factor beta receptor

  1992cited by this paper
• Interaction of the p85 subunit of PI 3‐kinase and its N‐terminal SH2 domain with a PDGF receptor phosphorylation site: structural features and analysis of conformational changes.

  1992cited by this paper
• Phosphatidylinositol 3′‐kinase is activated by association with IRS‐1 during insulin stimulation.

  1992cited by this paper
• Nucleotide sequence of the ampC-ampR region from the chromosome of Yersinia enterocolitica

  1992cited by this paper
• Tyr721 regulates specific binding of the CSF‐1 receptor kinase insert to PI 3′‐kinase SH2 domains: a model for SH2‐mediated receptor‐target interactions.

  1992cited by this paper
• SH2 domains prevent tyrosine dephosphorylation of the EGF receptor: identification of Tyr992 as the high‐affinity binding site for SH2 domains of phospholipase C gamma.

  1992cited by this paper
• Steps Towards Life: A Perspective on Evolution

  1992cited by this paper
• c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase.

  1991cited by this paper
• Hepatocyte growth factor/hepatopoietin A stimulates the growth of rat kidney proximal tubule epithelial cells (RPTE), rat nonparenchymal liver cells, human melanoma cells, mouse keratinocytes and stimulates anchorage-independent growth of SV-40 transformed RPTE.

  1991cited by this paper
• Oncogenes and signal transduction.

  1991influential reference
• Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor.

  1991cited by this paper
• Cloning of PI3 kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinases.

  1991cited by this paper
• cDNA cloning of a novel 85 kd protein that has SH2 domains and regulates binding of PI3-kinase to the PDGF beta-receptor.

  1991cited by this paper
• Characterization of two 85 kd proteins that associate with receptor tyrosine kinases, middle-T/pp60c-src complexes, and PI3-kinase.

  1991cited by this paper
• Dot-blot hybridization: quantitative analysis with direct beta counting.

  1991cited by this paper
• A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor.

  1991cited by this paper
• A phosphatidylinositol-3 kinase binds to platelet-derived growth factor receptors through a specific receptor sequence containing phosphotyrosine

  1991cited by this paper
• The tyrosine-phosphorylated hepatocyte growth factor/scatter factor receptor associates with phosphatidylinositol 3-kinase.

  1991cited by this paper
• Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical system.

  1991cited by this paper
• A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1

  1991cited by this paper
• SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins.

  1991cited by this paper
• Identification of the major autophosphorylation site of the Met/hepatocyte growth factor receptor tyrosine kinase.

  1991cited by this paper
• Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells

  1990cited by this paper
• Phosphoinositide kinases.

  1990cited by this paper
• The SIF binding element confers sis/PDGF inducibility onto the c‐fos promoter.

  1990cited by this paper
• Interactions of phosphatidylinositol kinase, GTPase-activating protein (GAP), and GAP-associated proteins with the colony-stimulating factor 1 receptor

  1990cited by this paper
• trans-repression of the mouse c-fos promoter: a novel mechanism of Fos-mediated trans-regulation.

  1989cited by this paper
• Tyrosine kinase receptor indistinguishable from the c-met protein

  1989cited by this paper
• Autophosphorylation of the PDGF receptor in the kinase insert region regulates interactions with cell proteins.

  1989cited by this paper
• Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

  1988cited by this paper
• Sequence and comparative analysis of three Enterobacter cloacae ampC beta-lactamase genes and their products.

  1988cited by this paper
• The protein kinase family: conserved features and deduced phylogeny of the catalytic domains.

  1988cited by this paper
• Scatter factor is a fibroblast-derived modulator of epithelial cell mobility

  1987cited by this paper
• Proteins

  1987cited by this paper
• Multiple protein-binding sites in the 5'-flanking region regulate c-fos expression

  1986cited by this paper
• Sequence of the Citrobacter freundii OS60 chromosomal ampCβ‐lactamase gene

  1986cited by this paper
• Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation

  1985cited by this paper

• Tyrosine-Mediated Static and Dynamic Quenching of a Receptor Tyrosine Kinase Biosensor Reveals Inhibitor Binding Modes and Kinase Conformations.

  2025cites this paper
• Optimal injection sites for therapeutic angiogenesis: HGF-mediated regulation of HIF-1α via MAPK/PI3K pathways in hypoxic endothelial cells.

  2025cites this paper
• MET Activation in Lung Cancer and Response to Targeted Therapies

  2025cites this paper
• Unlocking c-MET: A comprehensive journey into targeted therapies for breast cancer.

  2024cites this paper
• Metabolic alterations in hereditary and sporadic renal cell carcinoma

  2024cites this paper
• Thrombin Priming Promotes the Neuroprotective Effects of Human Wharton's Jelly-Derived Mesenchymal Stem Cells Via the HGF/AKT/STAT3 Signaling Pathway

  2024cites this paper
• Recording and classifying MET receptor mutations in cancers

  2024cites this paper
• An Observatory for the MET Oncogene: A Guide for Targeted Therapies

  2023cites this paper
• MET∆14 promotes a ligand-dependent, AKT-driven invasive growth

  2022cites this paper
• Roles of the HGF/Met signaling in head and neck squamous cell carcinoma: Focus on tumor immunity (Review).

  2020cites this paper
• Signaling Determinants of Glioma Cell Invasion.

  2020cites this paper
• Combination therapy of gefitinib and miR-30a-5p may overcome acquired drug resistance through regulating the PI3K/AKT pathway in non-small cell lung cancer

  2020cites this paper
• Regulation of Schwann cells and osteoclasts with an emphasis on NF1-deficient cells

  2019cites this paper
• Assembly of novel, nuclear dimers of the PI3-Kinase regulatory subunits underpins the pro-proliferative activity of the Cdc42-activated tyrosine kinase, ACK

  2019influential citation
• Oncogene addiction as a foundation of targeted cancer therapy: The paradigm of the MET receptor tyrosine kinase.

  2019cites this paper
• The Role of PI3K in Met Driven Cancer: A Recap

  2018cites this paper
• Qualitative and semi-quantitative analysis of signal transduction networks

  2018influential citation
• Overexpression-mediated activation of MET in the Golgi promotes HER3/ERBB3 phosphorylation

  2018cites this paper
• Conséquences de la dérégulation de MET sur le phénotype des cancers bronchiques non à petites cellules EGFR mutés devenus résistant aux inhibiteurs de tyrosine kinase d’EGFR

  2017cites this paper
• DERVED FROM SURVIVIN

  2017cites this paper
• HGF/Met Signaling in Head and Neck Cancer: Impact on the Tumor Microenvironment

  2016cites this paper
• The hepatocyte growth factor isoform NK2 activates motogenesis and survival but not proliferation due to lack of Akt activation.

  2016cites this paper
• Gene of the month: HGF

  2016cites this paper
• The role of HGF/c-MET signaling pathway in lymphoma

  2016cites this paper
• MET: a new promising biomarker in non-small-cell lung carcinoma.

  2015cites this paper
• The Met receptor tyrosine kinase: a key player in oncogenesis and drug resistance.

  2014cites this paper
• Physiological Signaling and Structure of the HGF Receptor MET

  2014cites this paper
• Enhanced Prediction of Src Homology 2 (SH2) Domain Binding Potentials Using a Fluorescence Polarization-derived c-Met, c-Kit, ErbB, and Androgen Receptor Interactome*

  2014cites this paper
• The Hepatocyte Growth Factor (HGF)/Met Axis: A Neglected Target in the Treatment of Chronic Myeloproliferative Neoplasms?

  2014cites this paper
• Regulation of EGF receptor dynamics by protein tyrosine phosphatases

  2013cites this paper
• HGF regulates VEGF expression via the c-Met receptor downstream pathways, PI3K/Akt, MAPK and STAT3, in CT26 murine cells.

  2013cites this paper
• Signaling determinants of glioma cell invasion.

  2013cites this paper
• WKYMVm‐induced cross‐talk between FPR2 and HGF receptor in human prostate epithelial cell line PNT1A

  2013cites this paper
• p85-RhoGDI2, a novel complex, is required for PSGL-1-induced β1 integrin-mediated lymphocyte adhesion to VCAM-1.

  2013cites this paper
• Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells

  2013cites this paper
• NUTRITIONAL AND HORMONAL MODULATION OF HUMAN MELANOMA PROGRESSION

  2013cites this paper
• Novel targets for VEGF-independent anti-angiogenic drugs

  2012cites this paper
• Anti-tumor effect of β-elemene in murine hepatocellular carcinoma cell line H22 depends on the level of c-Met downregulation

  2012cites this paper
• Hepatocyte growth factor and lung fibrosis.

  2012cites this paper
• A Novel Role for Bruton's Tyrosine Kinase in Hepatocyte Growth Factor-mediated Immunoregulation of Dendritic Cells*

  2011cites this paper
• Targeted Therapeutics in Cancer Treatment

  2011cites this paper
• Novel therapeutic target for head and neck squamous cell carcinoma: HGF-MET signaling pathway

  2011cites this paper
• Involvement of c-Met- and phosphatidylinositol 3-kinase dependent pathways in arsenite-induced downregulation of catalase in hepatoma cells.

  2011cites this paper
• Hepatocyte growth factor-induced c-Src-phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway inhibits dendritic cell activation by blocking IκB kinase activity.

  2011influential citation
• does not require interaction of p85 SH2 domains with p210 BCR/abl PI 3-kinase activation in BCR/abl-transformed hematopoietic cells

  2011cites this paper
• Role of zinc and zinc transporters in liver regeneration

  2011cites this paper
• Low temperature of radiofrequency ablation at the target sites can facilitate rapid progression of residual hepatic VX2 carcinoma

  2010cites this paper
• Cell delivery of Met docking site peptides inhibit angiogenesis and vascular tumor growth

  2010cites this paper
• The scatter factor signaling pathways as therapeutic associated target in cancer treatment.

  2010cites this paper
• TUMOR-ASSOCIATED PEPTIDES BINDING TO HUMAN LEUKOCYTE ANTIGEN (HLA) CLASS I OR II MOLECULES AND RELATED ANTI-CANCER VACCINE - European Patent Office - EP 1922334 B1

  2010cites this paper
• Predictive Computational Models of Mitogen-activated Protein Kinase Signaling Networks Driven by Quantitative Measurements of System Dynamics.

  2010cites this paper
• Novel Therapeutic Inhibitors of the c-Met Signaling Pathway in Cancer

  2009influential citation
• Attenuation of experimental liver fibrosis by hepatocyte growth factor gene delivery mediated by adenovirus Research Article

  2009cites this paper
• Hepatocyte Growth Factor/Scatter Factor and Prostate Cancer Metastasis

  2008cites this paper
• ErbB2 directly activates the exchange factor Dock7 to promote Schwann cell migration

  2008cites this paper
• Regulation of the Met Receptor-tyrosine Kinase by the Protein-tyrosine Phosphatase 1B and T-cell Phosphatase*

  2008cites this paper
• Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients

  2008influential citation
• The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis.

  2008cites this paper
• The Met tyrosine kinase receptor in development and cancer

  2008cites this paper
• UvA-DARE ( Digital Academic Repository ) Signaling pathways involved in B cell differentiation and disease : the role of Ral , Btk and Met

  2008cites this paper
• Pathway crosstalk between Ras/Raf and PI3K in promotion of M‐CSF‐induced MEK/ERK‐mediated osteoclast survival

  2008cites this paper
• Scatter factor-dependent branching morphogenesis: structural and histological features.

  2007cites this paper
• The role of the HGF regulatory factors in breast cancer

  2007cites this paper
• The androgen receptor negatively regulates the expression of c-Met: implications for a novel mechanism of prostate cancer progression.

  2007cites this paper
• CHAPTER 7 – Growth Factors in the Gastrointestinal Tract

  2006cites this paper
• The Smaller Isoforms of Ankyrin 3 Bind to the p85 Subunit of Phosphatidylinositol 3′-Kinase and Enhance Platelet-derived Growth Factor Receptor Down-regulation*

  2006cites this paper
• Tyrosine residues 654 and 670 in beta-catenin are crucial in regulation of Met-beta-catenin interactions.

  2006cites this paper
• Tyrosine residues 654 and 670 in β-catenin are crucial in regulation of Met–β-catenin interactions

  2006cites this paper
• SCATTER FACTORS IN TUMOR PROGRESSION

  2006cites this paper
• Species specificity of the Listeria monocytogenes InlB protein

  2006cites this paper
• Cell Motility in Cancer Invasion and Metastasis

  2006cites this paper
• Growth Factors in the Gastrointestinal Tract

  2006cites this paper
• The role of carbonic anhydrase IX overexpression in kidney cancer.

  2005cites this paper
• The C Terminus of RON Tyrosine Kinase Plays an Autoinhibitory Role*

  2005cites this paper
• Molecular Basis for a Direct Interaction between the Syk Protein-tyrosine Kinase and Phosphoinositide 3-Kinase*

  2005cites this paper
• Novel Mechanism of Interaction of p85 Subunit of Phosphatidylinositol 3-Kinase and ErbB3 Receptor-derived Phosphotyrosyl Peptides*

  2005cites this paper
• A Selective Small Molecule c-MET Inhibitor, PHA665752, Cooperates with Rapamycin

  2005cites this paper
• The HGF/MET and WNT signaling pathways in B cell differentiation and neoplasia

  2005cites this paper
• Identification of C-Met Oncogene as a Broadly Expressed Tumor-Associated Antigen Recognized by Cytotoxic T-Lymphocytes

  2004cites this paper
• Paxillin serves as an ERK-regulated scaffold for coordinating FAK and Rac activation in epithelial morphogenesis.

  2004cites this paper
• Suppression of Adriamycin-induced Apoptosis by Sustained Activation of the Phosphatidylinositol-3′-OH kinase-Akt Pathway*

  2004cites this paper
• Kinase Cells Transformed by the Oncogenic TPR-MET Tyrosine A Novel Small Molecule Met Inhibitor Induces Apoptosis in Updated

  2003cites this paper
• Keratinocyte-specific Pten deficiency results in epidermal hyperplasia, accelerated hair follicle morphogenesis and tumor formation.

  2003cites this paper
• Osteopontin contributes to hepatocyte growth factor-induced tumor growth and metastasis formation.

  2003cites this paper
• A novel small molecule met inhibitor induces apoptosis in cells transformed by the oncogenic TPR-MET tyrosine kinase.

  2003cites this paper
• IL-12 p40 Homodimer-Dependent Macrophage Chemotaxis and Respiratory Viral Inflammation Are Mediated through IL-12 Receptor β1 1

  2003cites this paper
• Met receptor overexpression and oncogenic Ki-ras mutation cooperate to enhance tumorigenicity of colon cancer cells in vivo.

  2003cites this paper
• The hepatocyte growth factor/Met pathway controls proliferation and apoptosis in multiple myeloma

  2003cites this paper
• Physiological functions of Pten in mouse tissues.

  2003cites this paper
• Expression of a mutated form of the p85alpha regulatory subunit of phosphatidylinositol 3-kinase in a Hodgkin's lymphoma-derived cell line (CO).

  2002cites this paper
• Preferential binding of Grb2 or phosphatidylinositol 3-kinase to the met receptor has opposite effects on HGF-induced myoblast proliferation.

  2002cites this paper
• Localization and possible role of two different alpha v beta 3 integrin conformations in resting and resorbing osteoclasts.

  2002cites this paper
• Hepatocyte growth factor triggers signaling cascades mediating vascular smooth muscle cell migration.

  2002cites this paper
• Concomitant activation of the PI3K-Akt and the Ras-ERK signaling pathways is essential for transformation by the V-SEA tyrosine kinase oncogene

  2002influential citation
• Heregulin-dependent Activation of Phosphoinositide 3-Kinase and Akt via the ErbB2/ErbB3 Co-receptor*

  2001cites this paper
• Tyrosine Phosphorylation of p85 Relieves Its Inhibitory Activity on Phosphatidylinositol 3-Kinase*

  2001cites this paper
• Differences in survival‐promoting effects and intracellular signaling properties of BDNF and IGF‐1 in cultured cerebral cortical neurons

  2001cites this paper
• Scatter factors and invasive growth.

  2001cites this paper
• Ligand-regulated Binding of FAP68 to the Hepatocyte Growth Factor Receptor*

  2001cites this paper
• Phosphoinositide 3‐kinase, but not mitogen‐activated protein kinase, pathway is involved in hepatocyte growth factor‐mediated protection against bile acid‐induced apoptosis in cultured rat hepatocytes

  2001cites this paper